Sign Up
Stories
Innovations in Biopharma and Healthcare
Share
Healthcare Innovations: Breakthroughs an...
ADOCIA Files 2023 Registration Document
AI Partnerships Drive Drug Discovery
Advancements in Cancer Treatment and Mar...
Overview
API
NeoGenomics promotes Warren Stone as Chief Commercial Officer and Melody Harris as Chief Operations Officer to drive operational efficiencies and innovation. Metsera launches to revolutionize obesity and metabolic disease treatments with a $290 million financing, offering advanced therapies. Cellares introduces Cell Q, an automated quality control workcell for cell therapy manufacturing, boosting capacity and reducing costs significantly.
Ask a question
How could Cellares' automation of cell therapy quality control influence the scalability and accessibility of cell-based treatments globally?
How might NeoGenomics' leadership changes impact its market positioning and future growth strategies?
What potential breakthroughs can be expected from Metsera's advanced weight loss medicines in the obesity market?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Apr 2024
Coverage